Health Catalyst Inc reports results for the quarter ended June 30 - Earnings Summary

• Health Catalyst Inc HCAT.OQ reported quarterly adjusted earnings of 4 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 12 cents. The mean expectation of eleven analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from zero cents to 8 cents per share.

• Revenue rose 6.3% to $80.72 million from a year ago; analysts expected $80.61 million.

• Health Catalyst Inc's reported EPS for the quarter was a loss of 59 cents​.

• The company reported a quarterly loss of $40.98 million.

• Health Catalyst Inc shares had risen by 1.3% this quarter and lost 46.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 39.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the software peer group is also "buy"

• Wall Street's median 12-month price target for Health Catalyst Inc is $6.50, about 43.2% above its last closing price of $3.69

This summary was machine generated from LSEG data August 8 at 03:18 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)